GlassScriptPhysician profile
Mrinal Koul
NPI 1114067527
$2,103.89
in general payments reported to CMS, 2019-2025
15 companies · $28.16 in 2025
The $28.16 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.40 · 2020: $76.64 · 2021: $59.44 · 2022: $86.85 · 2023: $1,646 · 2024: $118 · 2025: $28.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $1,646 · Food and Beverage: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $1,646.29 |
| Food and Beverage | $146.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $1,646.29 | 2023 | |
| Lupin INC. | $77.33 | 2019-2020 | |
| Hologic Sales and Service, LLC | $62.05 | 2024-2025 | Aptima |
| Organon LLC | $45.89 | 2024 | |
| Agile Therapeutics, INC. | $44.06 | 2021 | |
| Abbvie INC. | $37.87 | 2019-2020 | |
| Glaxosmithkline, LLC. | $35.84 | 2019 | |
| Evofem Biosciences, INC. | $29.39 | 2021-2022 | |
| Genzyme Corporation | $23.20 | 2022 | |
| Mylan Pharmaceuticals INC. | $19.99 | 2022 | |
| Exeltis, USA INC. | $19.67 | 2024 | Slynd |
| Coopersurgical, INC. | $18.66 | 2024 | Summit Doppler |
| Becton, Dickinson and Company | $17.33 | 2022 | |
| Amag Pharmaceuticals, INC. | $14.00 | 2019 | |
| Scynexis, INC. | $12.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mrinal Koul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.